Aion Therapeutic Stock Price, News & Analysis
Company Description
Aion Therapeutic (OTC Link: ANTCF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.8M.
ANTCF stock has declined 63.6% over the past year. Shares last traded at $0.0020.
This page provides a comprehensive overview of ANTCF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aion Therapeutic (ANTCF) stock last traded at $0.0020. Over the past 12 months, the stock has lost 63.6%. At a market capitalization of $1.8M, ANTCF is classified as a micro-cap stock with approximately 475.1M shares outstanding.
Latest News
Aion Therapeutic has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all ANTCF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ANTCF Company Profile & Sector Positioning
Aion Therapeutic (ANTCF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ANTCF often look at related companies in the same sector, including STEMTECH CORPORATION (STEK), Sibannac (SNNC), Biotech Medics (BMCS), Software Effective Solutions (SFWJ), and Endexx Corp (EDXC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ANTCF's relative position within its industry.